Ads
related to: cited scientific journalsonlinelibrary.wiley.com has been visited by 10K+ users in the past month
Search results
The EPA Cop Who Became a Warrior for ‘Forever Chemicals’
The Wall Street Journal· 6 hours agoDourson concluded that the safe level for humans was at least 30 times the EPA’s health guidance at...
Why Scientific Fraud Is Suddenly Everywhere
New York Magazine· 1 day agoLast week, scientific publisher Wiley decided to shutter 19 scientific journals after retracting 11,300 sham papers. There is a large-scale ...
The evidence suggests the DEA still has not come around on rescheduling marijuana
Reason.com· 12 hours agoJust a few years ago, the Drug Enforcement Administration (DEA) successfully fended off another in a...
Slowly Coming Off Ozempic, Wegovy May Prevent Rebound Weight Gain
Healthline via AOL· 7 days agoNew research suggests that slowly tapering off GLP-1 drugs like Ozempic and Wegovy while adopting...
Uncover the Hidden Data on This Medical Procedure in Children
Mercola· 3 hours ago“They do not publish the results [or] let any independent scientist in to look at that information,” Brian Hooker, chief scientific officer for Children’s Health Defense, said. In 1962, children received just five vaccine doses.
Losing the importance of academic libraries - open access in the sciences - a dubious promise of...
Weston Forum· 3 days agoFor centuries, libraries have been the place where scientific knowledge is stored and made...
WSJ: Russia tested space-based anti-satellite weapon with potential nuclear capabilities in 2022
Kyiv Independent via Yahoo News· 6 days agoThe officials said that Russia had launched a satellite into space in February 2022 to test...
Time to Reconsider Polygraph Reliability and Admissibility in New Jersey | New Jersey Law Journal
Law.com· 7 days agoThis article considers polygraph use in criminal cases in light of New Jersey’s adoption of the...
Star USC scientist faces scrutiny — retracted papers and a paused drug trial
LA Times via Yahoo News· 6 days agoUSC's Berislav Zlokovic has faced questions about the integrity of his research. Since a...
GSK says late-stage trials of potential blockbuster asthma drug met their goals
Morningstar· 1 day agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than GBP3 billion ($3.8 billion) met their goals. GSK (GSK) (UK:GSK) said both trials of depemokimab ...
Ad
related to: cited scientific journalsonlinelibrary.wiley.com has been visited by 10K+ users in the past month
